Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $107.8800 (5.37%) ($103.3400 - $108.0400) on Wed. Mar. 4, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.53% (three month average) | RSI | 69 | Latest Price | $107.8800(5.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1% a day on average for past five trading days. | Weekly Trend | LGND advances 2.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(58%) IWC(55%) XBI(55%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.265% in a week (0% probabilities). VIXM(-33%) VXX(-20%) TLT(-14%) UUP(-5%) SHY(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.265% (StdDev 2.53%) | Hourly BBV | 0 () | Intraday Trend | 4.1% | | | |
|
5 Day Moving Average | $102(5.76%) | 10 Day Moving Average | $101.5(6.29%) | 20 Day Moving Average | $98.84(9.15%) | To recent high | -1.1% | To recent low | 24.7% | Market Cap | $1.734b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |